{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:32:07Z","timestamp":1794324727276,"version":"4.9.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-006-020 -"],"award-info":[{"award-number":["111-2314-B-006-020 -"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-006-055 -"],"award-info":[{"award-number":["NSTC 112-2314-B-006-055 -"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH-10902029"],"award-info":[{"award-number":["NCKUH-10902029"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH-11106017"],"award-info":[{"award-number":["NCKUH-11106017"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.biopha.2024.116759","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T07:20:37Z","timestamp":1716448837000},"page":"116759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Empagliflozin attenuates doxorubicin-induced cardiotoxicity by inhibiting the JNK signaling pathway"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9442-2786","authenticated-orcid":false,"given":"Hsien-Yuan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsien","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Yen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.116759_bib1","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1038\/s41598-021-86652-x","article-title":"Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy","volume":"11","author":"Chang","year":"2021","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.biopha.2024.116759_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0022-2828(87)80392-9","article-title":"Subcellular effects of adriamycin in the heart: a concise review","volume":"19","author":"Singal","year":"1987","journal-title":"J. Mol. Cell Cardiol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116759_bib3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","article-title":"Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood","volume":"324","author":"Lipshultz","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.116759_bib4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.116759_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"H: cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"12","key":"10.1016\/j.biopha.2024.116759_bib6","first-page":"3730","article-title":"The CO\/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy","volume":"117","author":"Suliman","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.biopha.2024.116759_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem. Pharmacol."},{"issue":"17","key":"10.1016\/j.biopha.2024.116759_bib8","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/CIRCULATIONAHA.115.017443","article-title":"Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification","volume":"133","author":"Li","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.biopha.2024.116759_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1091581815614261","article-title":"JAK2\/STAT3 pathway mediates protection of metallothionein against doxorubicin-induced cytotoxicity in mouse cardiomyocytes","volume":"35","author":"Rong","year":"2016","journal-title":"Int. J. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116759_bib10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/1440-1681.13225","article-title":"Doxorubicin-induces NFAT\/Fas\/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways","volume":"47","author":"Shati","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"41","key":"10.1016\/j.biopha.2024.116759_bib11","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.biopha.2024.116759_bib12","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.biopha.2024.116759_bib13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2024.116759_bib14","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2024.116759_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biopha.2024.116759_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-017-6741-2","article-title":"Mechanistic insights of empagliflozin-mediated cardiac benefits: nearing the starting line: editorial to: \"empagliflozin improves left ventricular diastolic dysfunction in a genetic model of type 2 diabetes\" by N. hammoudi et al","volume":"31","author":"Gupte","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2024.116759_bib17","article-title":"Pentraxin 3 regulates tyrosine kinase inhibitor-associated cardiomyocyte contraction and mitochondrial dysfunction via ERK\/JNK signalling pathways","volume":"157","author":"Chen","year":"2023","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother"},{"issue":"12","key":"10.1016\/j.biopha.2024.116759_bib18","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.7150\/thno.23207","article-title":"The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling","volume":"8","author":"Hsu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.116759_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301186","article-title":"HLA-E(high) \/HLA-G(high) \/HLA-II(low) human iPSC-derived cardiomyocytes exhibit low immunogenicity for heart regeneration","author":"Fang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.biopha.2024.116759_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12933-020-01040-5","article-title":"Empagliflozin prevents doxorubicin-induced myocardial dysfunction","volume":"19","author":"Sabatino","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"42","key":"10.1016\/j.biopha.2024.116759_bib21","doi-asserted-by":"crossref","first-page":"36331","DOI":"10.1074\/jbc.M111.272146","article-title":"Inhibition of c-Jun-N-terminal kinase increases cardiac peroxisome proliferator-activated receptor alpha expression and fatty acid oxidation and prevents lipopolysaccharide-induced heart dysfunction","volume":"286","author":"Drosatos","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2024.116759_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/eji.201343506","article-title":"c-Jun NH2 -terminal kinase is a critical node in the death of CD4+ CD8+ thymocytes during Salmonella enterica serovar Typhimurium infection","volume":"44","author":"Deobagkar-Lele","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"14","key":"10.1016\/j.biopha.2024.116759_bib23","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1091\/mbc.E16-01-0038","article-title":"Biology of the cardiac myocyte in heart disease","volume":"27","author":"Peter","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2024.116759_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106448","article-title":"Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes","volume":"184","author":"Marfella","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.116759_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/biom14020243","article-title":"The role of the dysregulated JNK signaling pathway in the pathogenesis of human diseases and its potential therapeutic strategies: a comprehensive review","volume":"14","author":"Yan","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.biopha.2024.116759_bib26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bbrc.2017.09.153","article-title":"Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1\/JNK signaling pathway","volume":"493","author":"Yao","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2024.116759_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1139\/cjpp-2021-0289","article-title":"Midazolam suppresses ischemia\/reperfusion-induced cardiomyocyte apoptosis by inhibiting the JNK\/p38 MAPK signaling pathway","volume":"100","author":"Zhou","year":"2022","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116759_bib28","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00204-022-03298-y","article-title":"Dapagliflozin protects against doxorubicin-induced cardiotoxicity by restoring STAT3","volume":"96","author":"Chang","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116759_bib29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s10495-016-1231-8","article-title":"Sodium orthovanadate suppresses palmitate-induced cardiomyocyte apoptosis by regulation of the JAK2\/STAT3 signaling pathway","volume":"21","author":"Liu","year":"2016","journal-title":"Apoptosis\u00a0Int. J. Program. Cell death"},{"key":"10.1016\/j.biopha.2024.116759_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fcvm.2019.00150","article-title":"An update on the multifaceted Roles of STAT3 in the heart","volume":"6","author":"Harhous","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116759_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12860-018-0179-7","article-title":"Shikonin sensitizes A549 cells to TRAIL-induced apoptosis through the JNK, STAT3 and AKT pathways","volume":"19","author":"Guo","year":"2018","journal-title":"BMC Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116759_bib32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41401-023-01198-0","article-title":"Chemokine CCL2 promotes cardiac regeneration and repair in myocardial infarction mice via activation of the JNK\/STAT3 axis","volume":"45","author":"Wang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.biopha.2024.116759_bib33","article-title":"Salvianolic Acid B inhibits ferroptosis and apoptosis during myocardial ischemia\/reperfusion injury via decreasing the ubiquitin-proteasome degradation of GPX4 and the ROS-JNK\/MAPK Pathways","volume":"28","author":"Xu","year":"2023","journal-title":"Mol. (Basel, Switz. )"},{"key":"10.1016\/j.biopha.2024.116759_bib34","article-title":"Effect of N-n-butyl haloperidol iodide on ROS\/JNK\/Egr-1 signaling in H9c2 cells after hypoxia\/reoxygenation","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116759_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vph.2015.02.004","article-title":"NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis.","volume":"70","author":"Cattelan","year":"2015","journal-title":"Vasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116759_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13046-019-1424-4","article-title":"Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"issue":"1","key":"10.1016\/j.biopha.2024.116759_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbrc.2016.10.008","article-title":"Inhibiting c-Jun N-terminal kinase partially attenuates caffeine-dependent cell death without alleviating the caffeine-induced reduction in mitochondrial respiration in C2C12 skeletal myotubes","volume":"480","author":"Downs","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2024.116759_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111744","article-title":"Inhibition of glutaminolysis restores mitochondrial function in senescent stem cells","volume":"41","author":"Choudhury","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2024.116759_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12861-016-0112-2","article-title":"Co-culture with neonatal cardiomyocytes enhances the proliferation of iPSC-derived cardiomyocytes via FAK\/JNK signaling","volume":"16","author":"Ou","year":"2016","journal-title":"BMC Dev. Biol."},{"issue":"17","key":"10.1016\/j.biopha.2024.116759_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710146","article-title":"Dapagliflozin mitigates doxorubicin-caused myocardium damage by regulating AKT-mediated oxidative stress, cardiac remodeling, and inflammation","volume":"23","author":"Hsieh","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2024.116759_bib41","first-page":"4403","article-title":"Cardio-protective effect of dapagliflozin against doxorubicin induced cardiomyopathy in rats","volume":"26","author":"Belen","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116759_bib42","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2024.116759_bib43","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.2147\/DDDT.S418321","article-title":"SGLT1: a potential drug target for cardiovascular disease","volume":"17","author":"Zhao","year":"2023","journal-title":"Drug Des., Dev. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2024.116759_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063249","article-title":"Role of the ROS-JNK signaling pathway in hypoxia-induced atrial fibrotic responses in HL-1 cardiomyocytes","volume":"22","author":"Tsai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116759_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153597","article-title":"Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity","volume":"88","author":"Wu","year":"2021","journal-title":"Phytomedicine: Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.biopha.2024.116759_bib46","article-title":"Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress","volume":"120","author":"Hu","year":"2019","journal-title":"Biomed. Pharmacother.\u00a0Biomed. Pharmacother."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224006437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:54:55Z","timestamp":1781650495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224006437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":46,"alternative-id":["S0753332224006437"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116759","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin attenuates doxorubicin-induced cardiotoxicity by inhibiting the JNK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116759"}}